Use of recombinant HCV antigen in the serodiagnosis of hepatitis C virus infection: Significant improvement in HCV antibody detection as compared with the first generation HCV C100‐3 ELISA and the synthetic peptide EIA tests

D. Y. CHIEN, Q. ‐L CHOO, A. TABRIZI, C. KUO, J. McFARLAND, K. BERGER, C. LEE, J. R. SHUSTER, T. NGUYEN, D. L. MOYER, M. TONG, S. FURUTA, M. OMATA, C. T. FONG, G. TEGTMEIER, H. ALTER, E. SCHIFF, L. JEFFERS, M. HOUGHTON, G. KUO

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Use of recombinant HCV antigen in the serodiagnosis of hepatitis C virus infection: Significant improvement in HCV antibody detection as compared with the first generation HCV C100‐3 ELISA and the synthetic peptide EIA tests'. Together they form a unique fingerprint.

Medicine & Life Sciences